FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321798049> ?p ?o ?g. }

• W2321798049 endingPage "e1279" @default.
• W2321798049 startingPage "e1277" @default.
• W2321798049 abstract "Thrombotic thrombocytopenic purpura (TTP) is a microangiopatic thrombotic state associated with a deficiency on the cleavage function of the Von Willebrand factor polymers by a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13. We report a patient with relapsing TTP successfully treated with N-acetylcysteine (NAC) after failure of plasma exchange (PE) with steroids, rituximab, cyclophosphamide, vincristine, and azathioprine. A 51-year-old male who had an altered mental status while he was on rehabilitation for a previously treated TTP with a subsequent neurologic deficit. He was treated 7 days ago with PE plus steroids and subsequently discharged to our facility for rehabilitation. He was found to have a platelet level of 153,000/mm, hemoglobin decreased from 9.2 to 6.2 g/dL, creatinine raised from 1.0 to 2.4 mg/dL, and the peripheral smear showed schistocytes. A brain computed tomography showed a subacute infarction in the left frontal lobe and an abdominal-pelvic computed tomography disclosed a retroperitoneal hematoma. PE and steroids were started for 14 days. On day 15th, rituximab was added weekly for 10 cycles. A disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 activity level was 95% without platelet count improvement. We started cyclophosphamide, then vincristine, and finally azathioprine. His platelet were maintained above 150,000/mm for a few days. He had several episodes of sepsis after every chemotherapeutic drug. On day 135th, NAC was commenced at 150 mg/kg for 10 days along with PE and low-dose steroids for 10 days. Complete recover of platelet count was achieved and the patient was successfully discharged. Relapsing TTP is often difficult to manage and may last longer than expected carrying several comorbidities and complications. PE plus steroids are the mainstay of TTP treatment and Rituximab is the drug of choice after they have failed. The patient had a complete remission after NAC therapy. Hence, NAC likely can be considered an earlier choice of treatment after rituximab, before the use of chemotherapeutic agents, considering its toxic and adverse effects." @default.
• W2321798049 created "2016-06-24" @default.
• W2321798049 creator A5032617838 @default.
• W2321798049 creator A5053966732 @default.
• W2321798049 date "2016-09-01" @default.
• W2321798049 modified "2023-09-26" @default.
• W2321798049 title "N-Acetylcysteine for Relapsing Thrombotic Thrombocytopenic Purpura: More Evidence of a Promising Drug" @default.
• W2321798049 cites W1515110412 @default.
• W2321798049 cites W1566394771 @default.
• W2321798049 cites W1863071920 @default.
• W2321798049 cites W1968875627 @default.
• W2321798049 cites W1978735639 @default.
• W2321798049 cites W2009859487 @default.
• W2321798049 cites W2023589710 @default.
• W2321798049 cites W2083670536 @default.
• W2321798049 cites W2093312854 @default.
• W2321798049 cites W2096190607 @default.
• W2321798049 cites W2170807824 @default.
• W2321798049 doi "https://doi.org/10.1097/mjt.0000000000000386" @default.
• W2321798049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26720166" @default.
• W2321798049 hasPublicationYear "2016" @default.
• W2321798049 type Work @default.
• W2321798049 sameAs 2321798049 @default.
• W2321798049 citedByCount "20" @default.
• W2321798049 countsByYear W23217980492016 @default.
• W2321798049 countsByYear W23217980492017 @default.
• W2321798049 countsByYear W23217980492018 @default.
• W2321798049 countsByYear W23217980492019 @default.
• W2321798049 countsByYear W23217980492020 @default.
• W2321798049 countsByYear W23217980492021 @default.
• W2321798049 countsByYear W23217980492022 @default.
• W2321798049 countsByYear W23217980492023 @default.
• W2321798049 crossrefType "journal-article" @default.
• W2321798049 hasAuthorship W2321798049A5032617838 @default.
• W2321798049 hasAuthorship W2321798049A5053966732 @default.
• W2321798049 hasConcept C126322002 @default.
• W2321798049 hasConcept C141071460 @default.
• W2321798049 hasConcept C2776694085 @default.
• W2321798049 hasConcept C2776755627 @default.
• W2321798049 hasConcept C2776760755 @default.
• W2321798049 hasConcept C2778585876 @default.
• W2321798049 hasConcept C2779134260 @default.
• W2321798049 hasConcept C2779338263 @default.
• W2321798049 hasConcept C2779429289 @default.
• W2321798049 hasConcept C2780653079 @default.
• W2321798049 hasConcept C2780921031 @default.
• W2321798049 hasConcept C65245452 @default.
• W2321798049 hasConcept C71924100 @default.
• W2321798049 hasConcept C89560881 @default.
• W2321798049 hasConcept C90924648 @default.
• W2321798049 hasConceptScore W2321798049C126322002 @default.
• W2321798049 hasConceptScore W2321798049C141071460 @default.
• W2321798049 hasConceptScore W2321798049C2776694085 @default.
• W2321798049 hasConceptScore W2321798049C2776755627 @default.
• W2321798049 hasConceptScore W2321798049C2776760755 @default.
• W2321798049 hasConceptScore W2321798049C2778585876 @default.
• W2321798049 hasConceptScore W2321798049C2779134260 @default.
• W2321798049 hasConceptScore W2321798049C2779338263 @default.
• W2321798049 hasConceptScore W2321798049C2779429289 @default.
• W2321798049 hasConceptScore W2321798049C2780653079 @default.
• W2321798049 hasConceptScore W2321798049C2780921031 @default.
• W2321798049 hasConceptScore W2321798049C65245452 @default.
• W2321798049 hasConceptScore W2321798049C71924100 @default.
• W2321798049 hasConceptScore W2321798049C89560881 @default.
• W2321798049 hasConceptScore W2321798049C90924648 @default.
• W2321798049 hasIssue "5" @default.
• W2321798049 hasLocation W23217980491 @default.
• W2321798049 hasLocation W23217980492 @default.
• W2321798049 hasOpenAccess W2321798049 @default.
• W2321798049 hasPrimaryLocation W23217980491 @default.
• W2321798049 hasRelatedWork W1566884808 @default.
• W2321798049 hasRelatedWork W1999997909 @default.
• W2321798049 hasRelatedWork W2095002143 @default.
• W2321798049 hasRelatedWork W2096103309 @default.
• W2321798049 hasRelatedWork W2122205111 @default.
• W2321798049 hasRelatedWork W3008463185 @default.
• W2321798049 hasRelatedWork W3171162479 @default.
• W2321798049 hasRelatedWork W4285801222 @default.
• W2321798049 hasRelatedWork W4297537287 @default.
• W2321798049 hasRelatedWork W91661933 @default.
• W2321798049 hasVolume "23" @default.
• W2321798049 isParatext "false" @default.
• W2321798049 isRetracted "false" @default.
• W2321798049 magId "2321798049" @default.
• W2321798049 workType "article" @default.